WHAT IS THE REAL IMPACT OF THE HLA-DQA1*05 POLYMORPHISM ON INFLIXIMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE?

Joana Revés  1     Ana Catarina Bravo  1     Eleonora Davoli  2     Chiara Tognini  2     Ana Guedes  3     Maria Luisa Gloria  1     Carolina Palmela  1     Pedro Viana Baptista  2, 2     Alexandra Fernandes  2, 2     Joana Torres  1    
1 Hospital Beatriz Ângelo, Loures, Portugal
2 Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal
3 Glsmed Learning Health Sa, Lisboa, Portugal

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing